Back to competency map
Clinical competency
CYP2D6 genotype-informed dosing
Use pharmacogenetic information to anticipate altered ibogaine metabolism and exposure. The study identifies CYP2D6 activity as a major determinant of ibogaine clearance.
Primary clinical guidelineModern clinical
Looking for something specific? Ask Blossom
Guidelines
1
Courses
0
Providers
0
Protocols
1
Classification
Competency categories
Care stages
Roles
Protocol families
Source quality
Protocol paper
Linked sources
The guidelines, courses, and providers that evidence this competency. Full lists are a Blossom Pro feature.
Linked guidelines (1)
The pharmacokinetics and pharmacodynamics of ibogaine in opioid use disorder patients
IbogaineEvidence score: 90
Unlock every linked source
See all linked guidelines, courses, and providers behind this competency, plus the full competency graph.